| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 医药流通(元) | 662,905,839.88 | 341,406,644.15 | 526,240,019.75 | 286,122,615.24 |
| 医药制造(元) | 2,368,083,265.95 | 1,253,843,588.89 | 2,042,692,695.42 | 1,136,958,433.68 |
| 营业成本(元) | ||||
| 医药流通(元) | 587,384,680.78 | 289,902,042.43 | 441,772,373.07 | 245,412,630.12 |
| 医药制造(元) | 576,122,446.56 | 300,454,225.42 | 561,026,175.53 | 287,233,297.00 |
| 毛利(元) | ||||
| 医药流通(元) | 75,521,159.10 | 51,504,601.72 | 84,467,646.68 | 40,709,985.12 |
| 医药制造(元) | 1,791,960,819.39 | 953,389,363.47 | 1,481,666,519.89 | 849,725,136.68 |
| 毛利率(%) | ||||
| 医药流通(%) | 11.39 | 15.09 | 16.05 | 14.23 |
| 医药制造(%) | 75.67 | 76.04 | 72.53 | 74.74 |
| 收入构成(%) | ||||
| 医药流通(%) | 21.87 | 21.40 | 20.48 | 20.11 |
| 医药制造(%) | 78.13 | 78.60 | 79.52 | 79.89 |
| 毛利构成(%) | ||||
| 医药流通(%) | 4.04 | 5.13 | 5.39 | 4.57 |
| 医药制造(%) | 95.96 | 94.87 | 94.61 | 95.43 |